Blue Trust Inc’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.9K Buy
+46
New +$5K ﹤0.01% 1954
2025
Q3
Sell
-4
Closed -$208 2612
2025
Q2
$208 Sell
4
-1
-20% -$45 ﹤0.01% 2380
2025
Q1
$213 Buy
+5
New +$216 ﹤0.01% 2418
2024
Q1
Sell
-176
Closed -$6K 2402
2023
Q4
$6K Buy
+176
New +$4.62K ﹤0.01% 1760
2023
Q3
Sell
-1
Closed 2129
2023
Q2
$0 Buy
+1
New +$29 ﹤0.01% 2218
2022
Q4
Sell
-18
Closed -$1K 2322
2022
Q3
$1K Buy
18
+14
+350% +$719 ﹤0.01% 1925
2022
Q2
$0 Buy
+4
New +$198 ﹤0.01% 1927

Other funds holding GH

Blue Trust Inc's GH Position: Q2 2026 in Review

Blue Trust Inc opened a new position in Guardant Health (GH) in Q2 2026: 46 shares worth $6.9K. The stake represents ﹤0.01% of the portfolio and ranks #1954 among its holdings. This is a return to the name: Blue Trust Inc previously reported a position in GH as recently as Q2 2025.

Blue Trust Inc first reported a position in GH in Q2 2022 and has held it in 7 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Blue Trust Inc held 46 shares of Guardant Health worth $6.9K as of Q2 2026.
  • Guardant Health was a new Blue Trust Inc position in Q2 2026.
  • Guardant Health made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1954 holding.
  • Blue Trust Inc first reported a position in Guardant Health in Q2 2022 and has held it in 7 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.